Mylan, J&J Unit Reach Deal In Birth Control Drug Patent Row
Mylan Inc. said Thursday that it had settled patent-infringement litigation launched by a Johnson & Johnson unit that will allow Mylan to sell a generic version of birth control drug Ortho...To view the full article, register now.
Already a subscriber? Click here to view full article